3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasm Metastasis
5
Prostatic Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Recurrence
1
Non-Small Cell Lunch Cancer
1
Non Castrate Metastatic Prostate Cancer
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Glioblastoma
1
Esophageal Neoplasms
1
Carcinoma, Basal Cell
1
Basal Cell Nevus Syndrome
1
Interventions
Paclitaxel
1
NVP-BKM120
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Non-Small Cell Lunch Cancer
×
NVP-BKM120
×
Clear all
NCT01820325
2018-10-11
BASALT-2
Novartis
Phase 1
Terminated
6 enrolled